마우스 및 랫드에서 botulinum toxin type A의 단회 및 28일 반복투여 독성시험

Single and 28-day repeated dose toxicity studies of botulinum toxin type A in mice and rats

  • 전태원 (영남대학교 약학대학) ;
  • 김지영 (영남대학교 약학대학) ;
  • 현선희 (영남대학교 약학대학) ;
  • 김남희 (영남대학교 약학대학) ;
  • 이상규 (영남대학교 약학대학) ;
  • 김춘화 (영남대학교 약학대학) ;
  • 우희동 ((주)메디톡스 부설 미생물독소 연구소) ;
  • 양기혁 ((주)메디톡스 부설 미생물독소 연구소) ;
  • 정현호 (선문대학교 응용생물과학부) ;
  • 정태천 (영남대학교 약학대학)
  • 심사 : 2003.03.10
  • 발행 : 2003.03.31

초록

Single and 28-day repeated dose toxicity studies of botulimnn toxin type A were carried out in ICR mice and Sprague-Dawley rats, respectively. In the single dose toxicity study, botulinwn toxin was injected intraperitoneally to male and female mice at a single dose of 40, 59, 89 133 and 200 ng/10 ml saline/kg. All animals died from 59 ng/kg group. Some clinical signs, such as decrease in locomotor activity, dyspnea, prone position and ptosis, were observed in most of both sexes from 59 ng/kg group, but no signs were seen in all animals at 40 ng/kg group. The results showed that the median lethal dose of botulinum toxin might be in the range of 40-59 ng/kg in both sexes. In the repeated dose toxicity study, the test material was administered intradermally for 28 days at doses of 0 (vehicle-treated control), 1.25, 2.5, 5.0 and $10.0ng/head/50{\mu}{\ell}$ saline in male and female rats. No test material-related changes were noted in survivals, clinical signs, food and water consumptions and gross finding in any group. Botulinum toxin treatment significantly decreased the body weight gain rate in male of 5.0 ng/head group and over and in female of 10.0 ng/head group compared to vehicle-treated control. One or more relative organ weights (i.e., spleen, thymus, liver and kidney) were increased significantly from 5.0 ng/head group compared to vehicle-treated control in both sexes. Serum biochemistry revealed increases in aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatine phosphokinase, total protein and albumin in male, and increases in AST and ALT and decreases in $K^+$ and $Cl^-$ in female without dose-pendent manners. In the histopathological study, physical stimulation by needle caused slight inflammations of dennis. In addition, botulinum toxin treatment induced denervation of nerve cell and disuse of muscle, resulting in atrophy of skeletal muscle in both sexes from 2.5 ng/head group. When the antibodies to toxin were determined in all animals, a significant increase in serum antibodies was observed from 5.0 ng/head group. The results showed that the NOAEL of botulinum toxin might be 1.25 ng/head for 28-day repeated dose toxicity in rats.

키워드

참고문헌

  1. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology, 87:1044-1049, 1980
  2. Dolly JO, Black J, Williams RS, et al. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature, 307:457-460, 1984
  3. Black JD, Dolly JO. Interaction of $^{125}I$-labeled botulinum neurotoxins with narve terminals. I. Ultrastructural au-toradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell BioI, 103:521-534, 1986
  4. Black JD, Dolly JO. Interaction of $^{125}I$-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol, 103:535-544, 1986
  5. Pellizzari R, Rosseto O, Schiavo G, et aI. Tetanus and botulinum neurotoxins: mechanism of action and thera-peutic uses. Philosoph Trans Royal Soc Lond BIoI Sci, 354:259-268, 1999
  6. Stecher B, Weller U, Habermann E, et al. The light chain but not the heavy chain of botulinum type A toxin inhibits exocytosis from permeabilised adrenal chromaffin cells. FEBS Lett, 255:318-325, 1989
  7. Blasi J, Chapman ER, Yamasaki S, et al. Botulinum neurotoxin Cl blocks neuratransamitter release by means of cleaving HPC-1/syntaxin. EMBO J, 12:4821-4828, 1993
  8. Schiavo G, Shone CC, Rossetto O, et al. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J Biol Chem, 268:11516-11519, 1993
  9. Binz T, Blasi J, Yamasaki S, et al. Proteolysis of SNAP-25 by types E and A botulinum neurotoxtns. J Biol Chem, 269:1617-1620, 1994
  10. Foran P, Lawrence GW, Shone CC, et al. Botulinum neurotoxin Cl cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of carecholamine release. Biochemistry, 35:2630-2636, 1996
  11. Rizo J, Sudhof T. Mechanics of membrane fusion. Nature StructuraI Biol, 5:839-842, 1998
  12. Kang BH, Son HY, Ha CS, et al. Reference values of hematology and serum ehemistry in KTC: Sprague-Dawley rats. Korean J Lab Ani Sci, 11:141-145, 1995
  13. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulmum toxin. J Am Acad Dermatol, 43:249-259, 2000
  14. De Paiva A, Meunier FA, Molgo J, et al. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA, 96:3200-3205, 1999